Stock Market Reviews

ATON (AlphaTON Capital Corp.) News

Get the latest news, insights, and market updates on ATON (AlphaTON Capital Corp.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
  ADDRI-sponsored trial in Australia planned to enroll approximately 50 patients, led by A/Prof Steven Kao and Dr Melvin Chin; part of Cyncado’s international program for mesotheliomaDover, DE and Sydney, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (Cyncado), today announced a non-binding Letter of Intent (LOI) between Australia’s Asbestos and Dust Disea
  Nov 12, 2025 - $ATON
• Health In Tech and AlphaTON Capital to Unveil Blockchain Healthcare Vision at Web Summit Lisbon
  Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that three leaders seeking to shape the future of healthcare technology will take the stage at Web Summit this week to talk about a critical industry need: a better way to process insurance claims.
  Nov 11, 2025 - $ATON
• Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines
  Data from studies conducted by investigators at the National Cancer Institute at NCI laboratories, part of a multi-year research effort, will be presented at SITCDover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) (“AlphaTON”) and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (“Cyncado”), today announced a poster presentation at the Society for Immunotherapy of Cancer Annual Meeting, taking place November 5 to 9, 202
  Nov 7, 2025 - $ATON
• Can Telegram Crypto Make a Come Back? TON’s Corporate Treasury Plans Could See TON Price Hit $3.50 in November
  TON price is gaining renewed attention as Telegram crypto ecosystem developments converge with growing institutional cash flows, prompting the question: could Toncoin (TON) stage a comeback driven by major treasury plays and overall altcoin season momentum? With public companies such as TON Strategy Co. and AlphaTON Capital Corp. accumulating TON ...
  Oct 23, 2025 - $ATON
• Health In Tech, AlphaTON Partner to Develop ‘HITChain’ Blockchain Platform for Healthcare Claims on TON
  Health In Tech Inc. (NASDAQ:HIT) is one of the best performing new tech stocks to invest in. On September 30, Health In Tech and AlphaTON Capital Corp. (NASDAQ:ATON) signed a non-binding strategic Letter of Intent/LOI. This LOI is meant to jointly develop HITChain, which is a blockchain-enabled healthcare insurance claims processing platform to be built […]
  Oct 11, 2025 - $ATON
• Top Midday Gainers
  AlphaTON Capital (ATON) shares soared 87% amid heavy trading intraday after the company said Wednesd
  Oct 8, 2025 - $ATON
• Traders Eye Fed Minutes, Driving Muted Premarket Action for US Equity Futures
  US equity futures were flat ahead of Wednesday's opening bell as traders awaited minutes from the Fe
  Oct 8, 2025 - $ATON
• Sector Update: Health Care Stocks Advance Wednesday Afternoon
  Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index adding 0.3% and the Hea
  Oct 8, 2025 - $ATON
• TON on Telegram Ecosystem: AlphaTON Capital CIO Enzo Villani, Live at Nasdaq
  IPO Edge hosted a fireside chat on Oct. 2 at Nasdaq MarketSite with Enzo Villani, Chief Investment Officer and Board Member of AlphaTON Capital Corp. (Nasdaq: ATON). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the TON blockchain, Telegram safety along with its usage, communication privacy and more. Watch the interview below, or […]
  Oct 7, 2025 - $ATON